
In October 2025 NP Aerospace launched their LC300 product as a significantly refined and upgraded NP Aerospace platform and having recently completed Low Rate Initial Production (LRIP) they are entering their full rate programme, from January 2026. With the current contracted orders and the future product sales pipeline, NP Aerospace are expecting to produce over 100 LC300 vehicles over the next 12-18 months. This announcement coincides with the International Armoured Vehicles (IAV) Conference taking place in Farnborough, 20-22 January 26, where NP Aerospace will have a team in attendance.
Delivering unprecedented levels of protection, functionality and reliability based upon many years of user feedback, the NP Aerospace LC300 is being sought after and contracted by a multitude of global defence ministries and NonGovernment Organisations (NGO’s). Having qualified the LC300 to the latest Edition 3 of the international VPAM BRV and ERV (VR7) standards as well as PAS 300 ballistic and blast and PAS 301 vehicle performance criteria, NP Aerospace has ensured the platform provides optimum protection and remains road-legal for NATO and Europeanbased NGO customers, maximising the export potential to wider international user groups. The vehicle was the very first to be certified to VPAM VR7 BRV and ERV with a 2m side blast with a third row of seats in accordance with Edition 3 which uses biofidelic dummies, to understand the true impacts to the vehicle occupants.

David Petheram, MD & SVP, NP Aerospace Vehicle Systems, Services and Spares said: “we’ve worked very hard to ensure our newly upgraded armoured LC300 is suitably prepared in all regards to enter full rate production this month. Specifically, our integration, production and supply chain skill sets have been applied to this project to optimise the benefits to the procurer, the fleet manager and the user. What we now have is an excellent platform when viewed from all perspectives and we’re pleased to be able to offer it to global markets. The Civilian Armoured Vehicle (CAV) market offers great growth potential and is a significant area of focus for us as we continue to expand our team.”


















